$PBIO the company leads the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, announced the Company’s patented pressure cycling technology platform was featured as an integral part of a new, innovative workflow for the analysis of proteins from cancer biopsy samples. The workflow was presented in a plenary session at the Annual Meeting of the International Gynecologic Cancer Society (“IGCS”) on September 21, 2019 in Rio de Janeiro, Brazil.

#stocks